TrumpRx is primarily for people who pay for their prescriptions out-of-pocket. There may be cheaper generic options at direct ...
GoodRx projects Pharma Direct revenue to grow at least 30% year-over-year in 2026. Management anticipates continued acceleration in condition-specific subscriptions launched in late 2025, with weight ...
GoodRx Holdings, Inc. ( GDRX) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Fourth Quarter and Full Year 2025 Earnings ...
There's been a flurry of recent activity in the direct-to-consumer space as drug costs and spending continues to rise. | LOS ...
Q. My husband got COVID last fall. He has had great success from Paxlovid in the past, when he got it for free during the pandemic. This time he was charged $800 on his Medicare Drug Plan. That seems ...
According to other readers who have Medicare plus private insurance, the cost could be $700 to $800 for five days of medicine. That is out of reach for many people. Pfizer has had sales of over $25 ...
GoodRx reports that starting this year, the One Big Beautiful Bill expands HSA eligibility, covers more expenses, and raises FSA limits to $7,500.
Q. My husband got COVID-19 last fall. He has had great success with Paxlovid in the past, when he got it for free during the pandemic. This time, he was charged $800 on his Medicare Drug Plan. That ...
TrumpRx launched with more than 40 medications at discounted prices after negotiations with more than a dozen drug companies.
In February 2026, 60 Degrees Pharmaceuticals announced a partnership with GoodRx to offer eligible U.S. consumers savings of up to 30% on ARAKODA, the only FDA-approved, once-weekly prescription ...
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its fourth quarter and full year 2025 ...
SANTA MONICA, Calif., January 28, 2026--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading platform for prescription savings in the U.S., today announced it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results